Eisler Capital (US)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$810K Sell
7,805
-3,570
-31% -$364K 0.02% 399
2024
Q2
$1.1M Buy
11,375
+5,000
+78% +$461K 0.02% 430
2024
Q1
$574K Buy
+6,375
New +$540K 0.01% 468
2023
Q4
Sell
-80,093
Closed -$6.02M 289
2023
Q3
$5.7M Buy
80,093
+68,193
+573% +$5.1M 0.14% 124
2023
Q2
$917K Buy
+11,900
New +$921K 0.03% 259

Other funds holding CL

Eisler Capital (US)'s CL Position: Q3 2024 in Review

Eisler Capital (US) reduced its Colgate-Palmolive (CL) stake by 31% in Q3 2024, selling an estimated $364K and leaving 7,805 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #399.

Eisler Capital (US) first reported a position in CL in Q2 2023 and has held it in 5 quarters since. The position peaked at $5.7M in Q3 2023. 1,910 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Eisler Capital (US) held 7,805 shares of Colgate-Palmolive worth $810K as of Q3 2024.
  • Eisler Capital (US) sold 3,570 Colgate-Palmolive shares in Q3 2024, an estimated $364K.
  • Colgate-Palmolive made up 0.02% of Eisler Capital (US)'s portfolio in Q3 2024, its #399 holding.
  • Eisler Capital (US) first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 5 quarters since.
  • Eisler Capital (US)'s Colgate-Palmolive position peaked at $5.7M in Q3 2023.
  • 1,910 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.